Denmark vs Pre-demographic dividend: Access to anti-retroviral drugs, male
Denmark
93.0%
in 2023
Pre-demographic dividend
80.4%
in 2024
Denmark rank
7th
Pre-demographic dividend rank
5th
Access to anti-retroviral drugs, male over time
- Denmark
- Pre-demographic dividend
How they compare
Denmark currently reports 93.0% against 80.4% in Pre-demographic dividend, a difference of 12.6%.
That makes Denmark's figure about 1.2 times Pre-demographic dividend's.
Across all 24 years both countries report, Denmark has been ahead every year.
Denmark ranks 7th and Pre-demographic dividend ranks 5th of 141 countries.
Denmark has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Denmark | Pre-demographic dividend | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.4% | 5.7% | 43.7% | Denmark |
| 2010s | 77.6% | 37.6% | 40.0% | Denmark |
| 2020s | 91.2% | 69.2% | 22.0% | Denmark |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, male, Denmark or Pre-demographic dividend?
- Denmark, at 93.0% against 80.4% in Pre-demographic dividend as of 2023.
- What is the difference in access to anti-retroviral drugs, male between Denmark and Pre-demographic dividend?
- 12.6%, with Denmark ahead.
- How many years of comparable data are there for Denmark and Pre-demographic dividend?
- 24 years are reported by both, from 2000 to 2023.
- How do Denmark and Pre-demographic dividend rank globally for access to anti-retroviral drugs, male?
- Denmark ranks 7th and Pre-demographic dividend ranks 5th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, male (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.